| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -70,000 | 100% | $0.0201 | -$1,407 |
| Net | -1 | -70,000 | -100% | -$1,407 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Yair Schneid | 10%+ Owner | $2,099,780 | 17 Apr 2024 | ||
| Rochel Soffer | 10%+ Owner | $1,150,059 | 16 Apr 2024 | ||
| Dr. Nancy T. Chang | Director, 10%+ Owner | $499,979 | 24 Feb 2025 | ||
| Altamont Pharmaceutical Holdings, LLC | 10%+ Owner | $157,572 | 31 Dec 2023 | ||
| Mark Bachleda | Chief Commercial Officer | $11,770 | 16 Mar 2023 | ||
| Chris Degnan | Chief Financial Officer | $10,700 | 13 Mar 2023 | ||
| J. Mel Sorensen | President and CEO, Director | $3,920 | -$1,407 | -26% | 20 Nov 2025 |
| Linda West | Director | 01 Jul 2023 | |||
| Emmett Cunningham | Director | 14 Jun 2023 | |||
| Joel F. Sussman | Chief Accounting Officer | 01 May 2025 | |||
| HOLMLUND JON T | Chief Medical Officer | 28 Feb 2022 | |||
| Lawrence M. Alleva | Director | 24 Feb 2025 | |||
| Eugene P. Kennedy | Chief Medical Officer | 25 Feb 2023 | |||
| Michael R. Friedman | Director | 24 Feb 2025 | |||
| Michael Powell | Director | 14 Jun 2023 | |||
| Robert Alan Beardsley | Chief Operating Officer | 25 Feb 2023 | |||
| Jennifer Evans Stacey | Chief Legal & Compliance Officer | 25 Feb 2023 | |||
| Kevin G. Lokay | Director | 24 Feb 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| J. Mel Sorensen | GRTX | Common Stock | Sale | -26.4% | $1,407 | $0.0201 | -70,000 | 195,029 | 20 Nov 2025 | Direct |
| Joel F. Sussman | GRTX | Stock Option (Right to Buy) | Award | 2,000,000 | 2,000,000 | 01 May 2025 | Direct | |||
| J. Mel Sorensen | GRTX | Stock Option (Right to Buy) | Award | 6,000,000 | 6,000,000 | 01 May 2025 | Direct |